Description
Composition:
Each film-coated bilayer tablet contains:
-
Dapagliflozin – 10 mg
-
Vildagliptin (Sustained Release) – 100 mg
-
Excipients – q.s.
Dosage Form: Tablet
Route of Administration: Oral
Therapeutic Class:
SGLT2 Inhibitor + DPP-4 Inhibitor
Indicated for the treatment of type 2 diabetes mellitus to improve glycemic control.
Reviews
There are no reviews yet.